Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay

BACKGROUND: Drug-resistance and therapy failure due to drug-drug interactions are the main challenges in current treatment against Human Immunodeficiency Virus (HIV) infection. As such, there is a continuous need for the development of new and more potent anti-HIV drugs. Here we established a high-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Javier P, Hinkelmann, Bettina, Fleta-Soriano, Eric, Steinmetz, Heinrich, Jansen, Rolf, Diez, Juana, Frank, Ronald, Sasse, Florenz, Meyerhans, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852058/
https://www.ncbi.nlm.nih.gov/pubmed/24063434
http://dx.doi.org/10.1186/1475-2859-12-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852058/
https://www.ncbi.nlm.nih.gov/pubmed/24063434
http://dx.doi.org/10.1186/1475-2859-12-85

Ejemplares similares